Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: A network-based study

Journal of Proteome Research

Volumn 11, Issue 7, 2012, Pages 3664-3679

  Tripathi, Lokesh P ^a   Kambara, Hiroto ^b   Moriishi, Kohji ^b   Morita, Eiji ^b   Abe, Takayuki ^b   Mori, Yoshio ^b   Chen, Yi An ^a,c   Matsuura, Yoshiharu ^b   Mizuguchi, Kenji ^a,c  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CoreTG; GO; HCC; HCV; KEGG; OMIM; PA28 CoreTG; PPI; siRNA; TargetMine

Indexed keywords

CORE PROTEIN; INTERACTOME; PROTEASOME; PROTEASOME ACTIVATOR 28 GAMMA; PROTEOME; UNCLASSIFIED DRUG; VESICULAR TRANSPORT PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DATA BASE; FOLLOW UP; FUNCTIONAL PROTEOMICS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE SYSTEM; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION; VIRUS CAPSID; WILD TYPE;

ANIMALS; AUTOANTIGENS; CELL ADHESION MOLECULES; CELL DEATH; CELL LINE; GENE KNOCKOUT TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; QB-SNARE PROTEINS; RECOMBINANT PROTEINS; TRANSPORT VESICLES; VIRAL CORE PROTEINS; VIRUS RELEASE; VIRUS REPLICATION;

HEPATITIS C VIRUS; MIRIDAE; MUS MUSCULUS;

EID: 84863614097     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300121a     Document Type: Article

References (120)

1. Dubuisson, J. Hepatitis C virus proteins World J. Gastroenterol. 2007, 13 (17) 2406-15 (Pubitemid 46929495)
2. Moriishi, K.; Mochizuki, R.; Moriya, K.; Miyamoto, H.; Mori, Y.; Abe, T.; Murata, S.; Tanaka, K.; Miyamura, T.; Suzuki, T.; Koike, K.; Matsuura, Y. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (5) 1661-6 (Pubitemid 46214647)
3. Myrmel, H.; Ulvestad, E.; Asjo, B. The hepatitis C virus enigma APMIS 2009, 117 (5-6) 427-39
4. Tang, H.; Grise, H. Cellular and molecular biology of HCV infection and hepatitis Clin. Sci. (London) 2009, 117 (2) 49-65
5. Moradpour, D.; Penin, F.; Rice, C. M. Replication of hepatitis C virus Nat. Rev. Microbiol. 2007, 5 (6) 453-63 (Pubitemid 46780082)
6. Simmonds, P.; Bukh, J.; Combet, C.; Deleage, G.; Enomoto, N.; Feinstone, S.; Halfon, P.; Inchauspe, G.; Kuiken, C.; Maertens, G.; Mizokami, M.; Murphy, D. G.; Okamoto, H.; Pawlotsky, J. M.; Penin, F.; Sablon, E.; Shin, I. T.; Stuyver, L. J.; Thiel, H. J.; Viazov, S.; Weiner, A. J.; Widell, A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 2005, 42 (4) 962-73 (Pubitemid 41401136)
7. De Francesco, R.; Migliaccio, G. Challenges and successes in developing new therapies for hepatitis C Nature 2005, 436 (7053) 953-60 (Pubitemid 41191671)
8. Kato, N.; Mori, K.; Abe, K.; Dansako, H.; Kuroki, M.; Ariumi, Y.; Wakita, T.; Ikeda, M. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line Virus Res. 2009, 146 (1-2) 41-50
9. Murray, C. L.; Rice, C. M. Hepatitis C: An unsuspected drug target Nature 2010, 465 (7294) 42-4
10. Mori, Y.; Moriishi, K.; Matsuura, Y. Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver Int. J. Biochem. Cell Biol. 2008, 40 (8) 1437-42
11. Gao, G.; Luo, H. The ubiquitin-proteasome pathway in viral infections Can. J. Physiol. Pharmacol. 2006, 84 (1) 5-14 (Pubitemid 44011945)
12. Miyamoto, H.; Moriishi, K.; Moriya, K.; Murata, S.; Tanaka, K.; Suzuki, T.; Miyamura, T.; Koike, K.; Matsuura, Y. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein J. Virol. 2007, 81 (4) 1727-35 (Pubitemid 46214447)
13. Moriishi, K.; Okabayashi, T.; Nakai, K.; Moriya, K.; Koike, K.; Murata, S.; Chiba, T.; Tanaka, K.; Suzuki, R.; Suzuki, T.; Miyamura, T.; Matsuura, Y. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein J. Virol. 2003, 77 (19) 10237-49 (Pubitemid 37129667)
14. Moriishi, K.; Shoji, I.; Mori, Y.; Suzuki, R.; Suzuki, T.; Kataoka, C.; Matsuura, Y. Involvement of PA28gamma in the propagation of hepatitis C virus Hepatology 2010, 52 (2) 411-20
15. Suzuki, R.; Moriishi, K.; Fukuda, K.; Shirakura, M.; Ishii, K.; Shoji, I.; Wakita, T.; Miyamura, T.; Matsuura, Y.; Suzuki, T. Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin-independent but PA28gamma-dependent mechanism J. Virol. 2009, 83 (5) 2389-92
16. Chen, Y. A.; Tripathi, L. P.; Mizuguchi, K. TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery PLoS One 2011, 6 (3) e17844
17. Liu, M. C.; Akle, V.; Zheng, W.; Dave, J. R.; Tortella, F. C.; Hayes, R. L.; Wang, K. K. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis Biochem. J. 2006, 394 (Pt 3) 715-25
18. Stark, C.; Breitkreutz, B. J.; Reguly, T.; Boucher, L.; Breitkreutz, A.; Tyers, M. BioGRID: a general repository for interaction datasets Nucleic Acids Res. 2006, 34 (Database issue) D535-9
19. Turner, B.; Razick, S.; Turinsky, A. L.; Vlasblom, J.; Crowdy, E. K.; Cho, E.; Morrison, K.; Donaldson, I. M.; Wodak, S. J. iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence Database (Oxford) 2010, 2010, baq023
20. Cline, M. S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2007, 2 (10) 2366-82
21. Assenov, Y.; Ramirez, F.; Schelhorn, S. E.; Lengauer, T.; Albrecht, M. Computing topological parameters of biological networks Bioinformatics 2008, 24 (2) 282-4
22. Tripathi, L. P.; Kataoka, C.; Taguwa, S.; Moriishi, K.; Mori, Y.; Matsuura, Y.; Mizuguchi, K. Network based analysis of hepatitis C virus Core and NS4B protein interactions Mol. Biosyst. 2010, 6 (12) 2539-53
23. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 2000, 25 (1) 25-9 (Pubitemid 30257031)
24. Aoki-Kinoshita, K. F.; Kanehisa, M. Gene annotation and pathway mapping in KEGG Methods Mol. Biol. 2007, 396, 71-91 (Pubitemid 350190035)
25. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins Medicine (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), Online Mendelian Inheritance in Man, OMIM (TM). In 2010.
26. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate- A practical and powerful approach to multiple testing J. R. Statist. Soc. B 1995, 57 (1) 289-300
27. Noble, W. S. How does multiple testing correction work? Nat. Biotechnol. 2009, 27 (12) 1135-7
28. Linhart, C.; Halperin, Y.; Shamir, R. Transcription factor and microRNA motif discovery: the Amadeus platform and a compendium of metazoan target sets Genome Res. 2008, 18 (7) 1180-9 (Pubitemid 351931169)
29. Montgomery, S. B.; Griffith, O. L.; Sleumer, M. C.; Bergman, C. M.; Bilenky, M.; Pleasance, E. D.; Prychyna, Y.; Zhang, X.; Jones, S. J. ORegAnno: an open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variation Bioinformatics 2006, 22 (5) 637-40 (Pubitemid 43372833)
30. Okamoto, T.; Omori, H.; Kaname, Y.; Abe, T.; Nishimura, Y.; Suzuki, T.; Miyamura, T.; Yoshimori, T.; Moriishi, K.; Matsuura, Y. A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication J. Virol. 2008, 82 (7) 3480-9 (Pubitemid 351429923)
31. Pietschmann, T.; Lohmann, V.; Kaul, A.; Krieger, N.; Rinck, G.; Rutter, G.; Strand, D.; Bartenschlager, R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture J. Virol. 2002, 76 (8) 4008-21 (Pubitemid 34250565)
32. Kato, T.; Date, T.; Miyamoto, M.; Furusaka, A.; Tokushige, K.; Mizokami, M.; Wakita, T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon Gastroenterology 2003, 125 (6) 1808-17 (Pubitemid 37500445)
33. Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H. G.; Mizokami, M.; Bartenschlager, R.; Liang, T. J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 2005, 11 (7) 791-6 (Pubitemid 41021213)
34. Cao, W.; Sun, B.; Feitelson, M. A.; Wu, T.; Tur-Kaspa, R.; Fan, Q. Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis Int. J. Cancer 2009, 124 (12) 2886-92
35. Tacke, R. S.; Tosello-Trampont, A.; Nguyen, V.; Mullins, D. W.; Hahn, Y. S. Extracellular hepatitis C virus core protein activates STAT3 in human monocyte/macrophage/dendritic cells via an IL-6 autocrine pathway J. Biol. Chem. 2011, 10.1074/jbc.M110.217653
36. Waris, G.; Turkson, J.; Hassanein, T.; Siddiqui, A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication J. Virol. 2005, 79 (3) 1569-80 (Pubitemid 40459104)
37. Randall, G.; Panis, M.; Cooper, J. D.; Tellinghuisen, T. L.; Sukhodolets, K. E.; Pfeffer, S.; Landthaler, M.; Landgraf, P.; Kan, S.; Lindenbach, B. D.; Chien, M.; Weir, D. B.; Russo, J. J.; Ju, J.; Brownstein, M. J.; Sheridan, R.; Sander, C.; Zavolan, M.; Tuschl, T.; Rice, C. M. Cellular cofactors affecting hepatitis C virus infection and replication Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (31) 12884-9 (Pubitemid 47255249)
38. Lin, W.; Kim, S. S.; Yeung, E.; Kamegaya, Y.; Blackard, J. T.; Kim, K. A.; Holtzman, M. J.; Chung, R. T. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain J. Virol. 2006, 80 (18) 9226-35 (Pubitemid 44359995)
39. Tsutsumi, T.; Suzuki, T.; Moriya, K.; Shintani, Y.; Fujie, H.; Miyoshi, H.; Matsuura, Y.; Koike, K.; Miyamura, T. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice Hepatology 2003, 38 (4) 820-8 (Pubitemid 37221665)
40. Nanda, S. K.; Herion, D.; Liang, T. J. The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity Gastroenterology 2006, 130 (3) 794-809 (Pubitemid 43374529)
41. Jacobs, J. M.; Diamond, D. L.; Chan, E. Y.; Gritsenko, M. A.; Qian, W.; Stastna, M.; Baas, T.; Camp, D. G., 2nd; Carithers, R. L., Jr.; Smith, R. D.; Katze, M. G. Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients J. Virol. 2005, 79 (12) 7558-69 (Pubitemid 40756791)
42. Woodhouse, S. D.; Narayan, R.; Latham, S.; Lee, S.; Antrobus, R.; Gangadharan, B.; Luo, S.; Schroth, G. P.; Klenerman, P.; Zitzmann, N. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro Hepatology 2010, 52 (2) 443-53
43. Fujino, T.; Nakamuta, M.; Yada, R.; Aoyagi, Y.; Yasutake, K.; Kohjima, M.; Fukuizumi, K.; Yoshimoto, T.; Harada, N.; Yada, M.; Kato, M.; Kotoh, K.; Taketomi, A.; Maehara, Y.; Nakashima, M.; Enjoji, M. Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver Hepatol. Res. 2010, 40 (9) 923-9
44. MacPherson, J. I.; Sidders, B.; Wieland, S.; Zhong, J.; Targett-Adams, P.; Lohmann, V.; Backes, P.; Delpuech-Adams, O.; Chisari, F.; Lewis, M.; Parkinson, T.; Robertson, D. L. An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection PLoS One 2011, 6 (10) e25584
45. de Chassey, B.; Navratil, V.; Tafforeau, L.; Hiet, M. S.; Aublin-Gex, A.; Agaugue, S.; Meiffren, G.; Pradezynski, F.; Faria, B. F.; Chantier, T.; Le Breton, M.; Pellet, J.; Davoust, N.; Mangeot, P. E.; Chaboud, A.; Penin, F.; Jacob, Y.; Vidalain, P. O.; Vidal, M.; Andre, P.; Rabourdin-Combe, C.; Lotteau, V. Hepatitis C virus infection protein network Mol. Syst. Biol. 2008, 4, 230
46. Chazal, N.; Gerlier, D. Virus entry, assembly, budding, and membrane rafts Microbiol. Mol. Biol. Rev. 2003, 67 (2) 226-37 (Pubitemid 36693473)
47. Manes, S.; del Real, G.; Martinez, A. C. Pathogens: raft hijackers Nat. Rev. Immunol. 2003, 3 (7) 557-68 (Pubitemid 37328675)
48. Riethmuller, J.; Riehle, A.; Grassme, H.; Gulbins, E. Membrane rafts in host-pathogen interactions Biochim. Biophys. Acta 2006, 1758 (12) 2139-47 (Pubitemid 44879365)
49. Suzuki, T.; Suzuki, Y. Virus infection and lipid rafts Biol. Pharm. Bull. 2006, 29 (8) 1538-41 (Pubitemid 44166347)
50. Mannova, P.; Fang, R.; Wang, H.; Deng, B.; McIntosh, M. W.; Hanash, S. M.; Beretta, L. Modification of host lipid raft proteome upon hepatitis C virus replication Mol. Cell. Proteomics 2006, 5 (12) 2319-25 (Pubitemid 46040636)
51. Corless, L.; Crump, C. M.; Griffin, S. D.; Harris, M. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles J. Gen. Virol. 2010, 91 (Pt 2) 362-72
52. Lai, C. K.; Jeng, K. S.; Machida, K.; Lai, M. M. Hepatitis C virus egress and release depend on endosomal trafficking of core protein J. Virol. 2010, 84 (21) 11590-8
53. Jahn, R.; Scheller, R. H. SNAREs-engines for membrane fusion Nat. Rev. Mol. Cell. Biol. 2006, 7 (9) 631-43
54. Kreykenbohm, V.; Wenzel, D.; Antonin, W.; Atlachkine, V.; von Mollard, G. F. The SNAREs vti1a and vti1b have distinct localization and SNARE complex partners Eur. J. Cell Biol. 2002, 81 (5) 273-80 (Pubitemid 34568208)
55. Kunwar, A. J.; Rickmann, M.; Backofen, B.; Browski, S. M.; Rosenbusch, J.; Schoning, S.; Fleischmann, T.; Krieglstein, K.; Fischer von Mollard, G. Lack of the endosomal SNAREs vti1a and vti1b led to significant impairments in neuronal development Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (6) 2575-80
56. Mascia, L.; Langosch, D. Evidence that late-endosomal SNARE multimerization complex is promoted by transmembrane segments Biochim. Biophys. Acta 2007, 1768 (3) 457-66 (Pubitemid 46275608)
57. Offenhauser, C.; Lei, N.; Roy, S.; Collins, B. M.; Stow, J. L.; Murray, R. Z. Syntaxin 11 binds Vti1b and regulates late endosome to lysosome fusion in macrophages Traffic 2011, 12, 762-73
58. Bryceson, Y. T.; Chiang, S. C.; Darmanin, S.; Fauriat, C.; Schlums, H.; Theorell, J.; Wood, S. M. Molecular mechanisms of natural killer cell activation. J. Innate Immun. 2011, 3 (3) 216-26
59. Arneson, L. N.; Brickshawana, A.; Segovis, C. M.; Schoon, R. A.; Dick, C. J.; Leibson, P. J. Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity J. Immunol. 2007, 179 (6) 3397-401
60. Dabrazhynetskaya, A.; Ma, J.; Guerreiro-Cacais, A. O.; Arany, Z.; Rudd, E.; Henter, J. I.; Karre, K.; Levitskaya, J.; Levitsky, V. Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to co-localize with cytotoxic granules J. Cell. Mol. Med. 2011, 16, 129-41
61. Gholam, C.; Grigoriadou, S.; Gilmour, K. C.; Gaspar, H. B. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management Clin. Exp. Immunol. 2011, 163 (3) 271-83
62. How, P. C.; Shields, D. Tethering function of the caspase cleavage fragment of Golgi protein p115 promotes apoptosis via a p53-dependent pathway J. Biol. Chem. 2011, 286 (10) 8565-76
63. Radulescu, A. E.; Mukherjee, S.; Shields, D. The Golgi protein p115 associates with gamma-tubulin and plays a role in Golgi structure and mitosis progression J. Biol. Chem. 2011, 286 (24) 21915-26
64. Bouffard, P.; Hayashi, P. H.; Acevedo, R.; Levy, N.; Zeldis, J. B. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients J. Infect. Dis. 1992, 166 (6) 1276-80
65. Roxrud, I.; Raiborg, C.; Pedersen, N. M.; Stang, E.; Stenmark, H. An endosomally localized isoform of Eps15 interacts with Hrs to mediate degradation of epidermal growth factor receptor J. Cell Biol. 2008, 180 (6) 1205-18 (Pubitemid 351468475)
66. Salcini, A. E.; Chen, H.; Iannolo, G.; De Camilli, P.; Di Fiore, P. P. Epidermal growth factor pathway substrate 15, Eps15 Int. J. Biochem. Cell Biol. 1999, 31 (8) 805-9 (Pubitemid 29354077)
67. Barnaba, V. Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival J. Hepatol. 2010, 53 (4) 752-61
68. Hiroishi, K.; Ito, T.; Imawari, M. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence J. Gastroenterol. Hepatol. 2008, 23 (10) 1473-82
69. Kawai, T.; Akira, S. Toll-like receptor and RIG-I-like receptor signaling Ann. N.Y. Acad. Sci. 2008, 1143, 1-20
70. Sklan, E. H.; Charuworn, P.; Pang, P. S.; Glenn, J. S. Mechanisms of HCV survival in the host Nat. Rev. Gastroenterol. Hepatol. 2009, 6 (4) 217-27
71. Szabo, G.; Dolganiuc, A. Hepatitis C and innate immunity: recent advances Clin. Liver Dis. 2008, 12 (3) 675-92 (Pubitemid 351952475)
72. Taylor, D. R.; Silberstein, E. Innate immunity and hepatitis C virus: eluding the host cell defense Front. Biosci. 2009, 14, 4950-61
73. Legarda-Addison, D.; Hase, H.; O'Donnell, M. A.; Ting, A. T. NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling Cell Death Differ. 2009, 16 (9) 1279-88
74. Ye, X.; Lu, H.; Huo, K.; Chen, D. Finding a novel interacting protein of the hepatic carcinoma related gene MIP: NF-kappaB essential modulator (NEMO) Oncol. Rep. 2011, 25 (1) 231-5
75. Beraza, N.; Malato, Y.; Sander, L. E.; Al-Masaoudi, M.; Freimuth, J.; Riethmacher, D.; Gores, G. J.; Roskams, T.; Liedtke, C.; Trautwein, C. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage J. Exp. Med. 2009, 206 (8) 1727-37
76. Cruz-Munoz, M. E.; Veillette, A. Do NK cells always need a license to kill? Nat. Immunol. 2010, 11 (4) 279-80
77. Wang, K.; Song, Y.; Chen, D. B.; Zheng, J. Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells Biol. Reprod. 2008, 79 (4) 704-10
78. Singh, A. P.; Bafna, S.; Chaudhary, K.; Venkatraman, G.; Smith, L.; Eudy, J. D.; Johansson, S. L.; Lin, M. F.; Batra, S. K. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells Cancer Lett. 2008, 259 (1) 28-38 (Pubitemid 350235090)
79. Ostenfeld, M. S.; Bramsen, J. B.; Lamy, P.; Villadsen, S. B.; Fristrup, N.; Sorensen, K. D.; Ulhoi, B.; Borre, M.; Kjems, J.; Dyrskjot, L.; Orntoft, T. F. miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors Oncogene 2010, 29 (7) 1073-84
80. Johansen, C.; Vestergaard, C.; Kragballe, K.; Kollias, G.; Gaestel, M.; Iversen, L. MK2 regulates the early stages of skin tumor promotion Carcinogenesis 2009, 30 (12) 2100-8
81. Wang, C.; Zhou, J.; Wang, S.; Ye, M.; Fan, G.; Zou, H.; Jiang, C. Shotgun approach based comparative proteomic analysis of levo-tetrahydropalmatine- induced apoptosis in hepatocytes Toxicol. Lett. 2010, 194 (1-2) 8-15
82. Del Campo, J. A.; Romero-Gomez, M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J. Gastroenterol. 2009, 15 (40) 5014-9
83. Douglas, M. W.; George, J. Molecular mechanisms of insulin resistance in chronic hepatitis C World J. Gastroenterol. 2009, 15 (35) 4356-64
84. Shintani, Y.; Fujie, H.; Miyoshi, H.; Tsutsumi, T.; Tsukamoto, K.; Kimura, S.; Moriya, K.; Koike, K. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 2004, 126 (3) 840-8 (Pubitemid 38298332)
85. Cao, X.; Pobezinskaya, Y. L.; Morgan, M. J.; Liu, Z. G. The role of TRADD in TRAIL-induced apoptosis and signaling FASEB J. 2011, 25 (4) 1353-8
86. Zheng, L.; Bidere, N.; Staudt, D.; Cubre, A.; Orenstein, J.; Chan, F. K.; Lenardo, M. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1 Mol. Cell. Biol. 2006, 26 (9) 3505-13
87. Tellinghuisen, T. L.; Foss, K. L.; Treadaway, J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein PLoS Pathog. 2008, 4 (3) e1000032
88. Benedicto, I.; Molina-Jimenez, F.; Bartosch, B.; Cosset, F. L.; Lavillette, D.; Prieto, J.; Moreno-Otero, R.; Valenzuela-Fernandez, A.; Aldabe, R.; Lopez-Cabrera, M.; Majano, P. L. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection J. Virol. 2009, 83 (16) 8012-20
89. Bantel, H.; Schulze-Osthoff, K. Apoptosis in hepatitis C virus infection Cell Death Differ. 2003, 10 (Suppl 1) S48-58
90. Deng, L.; Adachi, T.; Kitayama, K.; Bungyoku, Y.; Kitazawa, S.; Ishido, S.; Shoji, I.; Hotta, H. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway J. Virol. 2008, 82 (21) 10375-85 (Pubitemid 352691171)
91. Fischer, R.; Baumert, T.; Blum, H. E. Hepatitis C virus infection and apoptosis World J. Gastroenterol. 2007, 13 (36) 4865-72 (Pubitemid 47496752)
92. Hanafy, S. M.; Shehata, O. H.; Farahat, N. M. Expression of apoptotic markers BCL-2 and Bax in chronic hepatitis C virus patients Clin. Biochem. 2010, 43 (13-14) 1112-7
93. Joyce, M. A.; Walters, K. A.; Lamb, S. E.; Yeh, M. M.; Zhu, L. F.; Kneteman, N.; Doyle, J. S.; Katze, M. G.; Tyrrell, D. L. HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice PLoS Pathog. 2009, 5 (2) e1000291
94. Kondo, Y.; Machida, K.; Liu, H. M.; Ueno, Y.; Kobayashi, K.; Wakita, T.; Shimosegawa, T.; Lai, M. M. Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6 J. Infect. Dis. 2009, 199 (5) 726-36
95. Anupam, R.; Datta, A.; Kesic, M.; Green-Church, K.; Shkriabai, N.; Kvaratskhelia, M.; Lairmore, M. D. Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival J. Biol. Chem. 2011, 286 (9) 7661-8
96. Mao, I.; Liu, J.; Li, X.; Luo, H. REGgamma, a proteasome activator and beyond? Cell. Mol. Life Sci. 2008, 65 (24) 3971-80
97. Tian, M.; Xiaoyi, W.; Xiaotao, L.; Guosheng, R. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis Cell. Mol. Biol. (Noisy-le-Grand) 2009, 55 (Suppl) OL1121-31
98. Zannini, L.; Buscemi, G.; Fontanella, E.; Lisanti, S.; Delia, D. REGgamma/PA28gamma proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number Cell Cycle 2009, 8 (15) 2399-407
99. Samuelsen, J. T.; Schwarze, P. E.; Huitfeldt, H. S.; Thrane, E. V.; Lag, M.; Refsnes, M.; Skarpen, E.; Becher, R. Regulation of rat alveolar type 2 cell proliferation in vitro involves type II cAMP-dependent protein kinase Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292 (1) L232-9
100. Bungyoku, Y.; Shoji, I.; Makine, T.; Adachi, T.; Hayashida, K.; Nagano-Fujii, M.; Ide, Y. H.; Deng, L.; Hotta, H. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells J. Gen. Virol. 2009, 90 (Pt 7) 1681-91
101. Lemon, S. M.; McKeating, J. A.; Pietschmann, T.; Frick, D. N.; Glenn, J. S.; Tellinghuisen, T. L.; Symons, J.; Furman, P. A. Development of novel therapies for hepatitis C Antiviral Res. 2010, 86 (1) 79-92
102. Lin, K. Development of novel antiviral therapies for hepatitis C virus Virol. Sin. 2010, 25 (4) 246-66
103. Chan, S. C.; Lo, S. Y.; Liou, J. W.; Lin, M. C.; Syu, C. L.; Lai, M. J.; Chen, Y. C.; Li, H. C. Visualization of the structures of the hepatitis C virus replication complex Biochem. Biophys. Res. Commun. 2011, 404 (1) 574-8
104. Dreyer, J. L. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions Mol. Biotechnol. 2011, 47 (2) 169-87
105. Camm, E. J.; Martin-Gronert, M. S.; Wright, N. L.; Hansell, J. A.; Ozanne, S. E.; Giussani, D. A. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring FASEB J. 2011, 25 (1) 420-7
106. Ning, B. F.; Ding, J.; Yin, C.; Zhong, W.; Wu, K.; Zeng, X.; Yang, W.; Chen, Y. X.; Zhang, J. P.; Zhang, X.; Wang, H. Y.; Xie, W. F. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma Cancer Res. 2010, 70 (19) 7640-51
107. Niehof, M.; Borlak, J. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas Gastroenterology 2008, 134 (4) 1191-202 (Pubitemid 351451974)
108. Hussain, K. M.; Leong, K. L.; Ng, M. M.; Chu, J. J. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71 J. Biol. Chem. 2011, 286 (1) 309-21
109. Helle, F.; Dubuisson, J. Hepatitis C virus entry into host cells Cell. Mol. Life Sci. 2008, 65 (1) 100-12 (Pubitemid 351152228)
110. Marshall, A.; Rushbrook, S.; Morris, L. S.; Scott, I. S.; Vowler, S. L.; Davies, S. E.; Coleman, N.; Alexander, G. Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: a pilot study Liver Transpl. 2005, 11 (4) 427-33 (Pubitemid 40533211)
111. Bard-Chapeau, E. A.; Li, S.; Ding, J.; Zhang, S. S.; Zhu, H. H.; Princen, F.; Fang, D. D.; Han, T.; Bailly-Maitre, B.; Poli, V.; Varki, N. M.; Wang, H.; Feng, G. S. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis Cancer Cell 2011, 19 (5) 629-39
112. Matsuo, K.; Delibegovic, M.; Matsuo, I.; Nagata, N.; Liu, S.; Bettaieb, A.; Xi, Y.; Araki, K.; Yang, W.; Kahn, B. B.; Neel, B. G.; Haj, F. G. Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2 J. Biol. Chem. 2010, 285 (51) 39750-8
113. Rios, E. J.; Piliponsky, A. M.; Ra, C.; Kalesnikoff, J.; Galli, S. J. Rabaptin-5 regulates receptor expression and functional activation in mast cells Blood 2008, 112 (10) 4148-57
114. Stenmark, H.; Vitale, G.; Ullrich, O.; Zerial, M. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion Cell 1995, 83 (3) 423-32
115. Edamoto, Y.; Hara, A.; Biernat, W.; Terracciano, L.; Cathomas, G.; Riehle, H. M.; Matsuda, M.; Fujii, H.; Scoazec, J. Y.; Ohgaki, H. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis Int. J. Cancer 2003, 106 (3) 334-41 (Pubitemid 36870393)
116. Laurent-Puig, P.; Zucman-Rossi, J. Genetics of hepatocellular tumors Oncogene 2006, 25 (27) 3778-86 (Pubitemid 43980473)
117. Park, K. J.; Choi, S. H.; Koh, M. S.; Kim, D. J.; Yie, S. W.; Lee, S. Y.; Hwang, S. B. Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2 Virus Res. 2001, 74 (1-2) 89-98 (Pubitemid 32168196)
118. Kawaguchi, T.; Yoshida, T.; Harada, M.; Hisamoto, T.; Nagao, Y.; Ide, T.; Taniguchi, E.; Kumemura, H.; Hanada, S.; Maeyama, M.; Baba, S.; Koga, H.; Kumashiro, R.; Ueno, T.; Ogata, H.; Yoshimura, A.; Sata, M. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 Am. J. Pathol. 2004, 165 (5) 1499-508 (Pubitemid 39435150)
119. Ma, Z.; Liu, Z.; Wu, R. F.; Terada, L. S. p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior Oncogene 2010, 29 (41) 5559-67
120. Spoden, G. A.; Rostek, U.; Lechner, S.; Mitterberger, M.; Mazurek, S.; Zwerschke, W. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply Exp. Cell Res. 2009, 315 (16) 2765-74